Verapamil and mild hyperkalemia in hemodialysis patients: a potentially hazardous association.
During the past 3 years, 3 patients undergoing intermittent hemodialysis (or about to do so) in our hospital developed a third-degree atrioventricular block while being treated with verapamil for blood pressure or supraventricular arrhythmia. In the 3 cases, mild hyperkalemia was concomitant. The medical history of these patients revealed no intrinsic cause of atrioventricular conduction disturbance. We report herein the 3 cases and draw attention to the risks of atrioventricular block in this particular context.
Letavernier
Emmanuel
E
Service de néphrologie et d'hémodialyse, CHU Pellegrin, Bordeaux, France. letavernieremmanuel@yahoo.fr
Couzi
Lionel
L
Delmas
Yahsou
Y
Moreau
Karine
K
Murcott
Olivier
O
de Précigout
Valérie
V
D001774:Blood Chemical Analysis; D005500:Follow-Up Studies; D006327:Heart Block / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects* / Q000379:methods; D018570:Risk Assessment; D012720:Severity of Illness Index; D014700:Verapamil / Q000009:adverse effects* / Q000627:therapeutic use
D014700:Verapamil